Cargando…
Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical Implications
Selection of inhibitor-resistant viral mutants is universal for viruses that display quasi-species dynamics, and hepatitis C virus (HCV) is no exception. Here we review recent results on drug resistance in HCV, with emphasis on resistance to the newly-developed, directly-acting antiviral agents, as...
Autores principales: | Perales, Celia, Quer, Josep, Gregori, Josep, Esteban, Juan Ignacio, Domingo, Esteban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664975/ https://www.ncbi.nlm.nih.gov/pubmed/26561827 http://dx.doi.org/10.3390/v7112902 |
Ejemplares similares
-
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
por: de Ávila, Ana I., et al.
Publicado: (2016) -
Extinction of Hepatitis C Virus by Ribavirin in Hepatoma Cells Involves Lethal Mutagenesis
por: Ortega-Prieto, Ana M., et al.
Publicado: (2013) -
Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus
por: Soria, María Eugenia, et al.
Publicado: (2018) -
Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant
por: Perales, Celia, et al.
Publicado: (2018) -
New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents
por: Quer, Josep, et al.
Publicado: (2010)